VICTORIA PRUSS: Open Payments
NPI 1518549286 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 20 payments from 10 companies in 2025. Trend: 2023 $720 · 2024 $4,110 · 2025 $651
Food & beverage: $566Education: $85
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $139 |
| UROGEN PHARMA, INC. | 4 | $137 |
| Janssen Biotech, Inc. | 3 | $116 |
| Sumitomo Pharma America, Inc. | 6 | $113 |
| AVYXA PHARMA, LLC | 1 | $34 |
| Dendreon Pharmaceuticals LLC | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| TOLMAR, INC. | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
Products named: Axonics, ERLEADA, JELMYTO, GEMTESA, ORGOVYX, LUTRATE DEPOT, PROVENGE, PLUVICTO.
Industry payments across MI — which companies pay providers there.
